Ian Campbell

Ian Campbell

Formal First Name

Ian Campbell is the CEO and Director of Neural Therapeutics, an ethnobotanical, drug-discovery company specializing in psychedelic-based medical therapeutics. Ian is an executive leader with an international reputation in the US, Canada, and Czech Republic. He has extensive experience in building effective teams, managing operations and product commercialization in the fields of environmental science and pharmacology. Prior to joining Neural Therapeutics, Ian was the Regional CEO of USA and Canada at Maccaferri, a private global engineering solutions firm, where he led the North America team to provide excellent customer experiences and profitable organic growth. He is also known for lobbying the United States Pharmacopeia to include new techniques for Impurity Analysis, sales efforts to the US-DEA for controlled substances, and a partnership with Health Canada that resulted in a leading drug counterfeit detection technology.

Professional Experience

Academic History


  • At Maccaferri, Ian was responsible for the Canadian office, where he contributed to regional growth through strategic planning and execution.

  • He was CEO and Managing Director of FLSmidth, involved in operations, product quality, project delivery, value engineering and supply chain.

  • He was also Global Product and Pharma Manager at PANalytical, where he managed multi-discipline cross-functional teams in global marketing.

  • He was a Sales Engineer at LECO, where he sold laboratory instrumentation for research and industrial control purposes.

  • He also had significant international exposure to the controlled substance regulators and led successful sales efforts to the US-DEA.

  • He created a partnership with Health Canada which resulted in a unique controlled substance scientific database for X-ray analysis.